Randy S. Wymore, PhD

Tulsa, OK
Director, OSU-CHS -CIMD Center for the Investigation of Morgellons Disease
Associate Professor of Pharmacology & Physiology
Oklahoma State University
Center for Health Sciences

2011 Wymore Abstract

Biography

Randy S. Wymore was born in Fresno, CA, where he spent the first half of his life. With transfer of college credits from Fresno Community College and Cal-State Fresno, he completed his B.S. degree in Physiology at the University of California, Davis. His entire time at UC Davis was spent as a Regents Scholar. Randy Wymore then entered the Ph.D. program at UC Irvine in the laboratory of K. George Chandy, MD, Ph.D. and devoted his work to the study of potassium channels in the heart and nervous system. He completed his Ph.D. in physiology and biophysics in 1995.

Dr. Wymore did his post-doctoral work on the characterization of potassium and pacemaker channels in the heart and nervous system in the lab of Ira Cohen, MD, Ph.D. at the State University of New York at Stony Brook. After living in California and New York, he moved to Oklahoma where he accepted a position at the University of Tulsa. After receiving tenure at the University of Tulsa, he moved across the Arkansas River to the Oklahoma State University Center for Health Sciences where his laboratory currently resides. Dr. Wymore is an Associate Professor of Pharmacology and Physiology. He is the course coordinator of the Medical Pharmacology Course and teaches cardiac, renal, autonomic nervous system, asthma and headache pharmacology to second year medical students and graduate students. He is Co-Course Coordinator of Introduction to the Patient, a two-year course and is Chair of the Curriculum Oversight Committee.

Dr. Wymore has been a coauthor on seventeen articles published in peer-reviewed scientific journals and has been a contributing author on one book and one review article. His most recent journal articles have been on the role of potassium channels in cancer. He spends the bulk of his time working on Morgellons Disease and is the Director of the OSU-CHS Center for the Investigation of Morgellons Disease.

Multiple bacterial species co-localized exclusively to active Morgellons lesions

Carol Hefley*@, Samantha Rice@# and Randy S. Wymore*
*Department of Pharmacology & Physiology, OSU-CHS, Tulsa, OK
@Oklahoma State University, Stillwater, OK
**Tulsa Area Biology Education and Research Consortium (TABERC)
#Tulsa Community College, Tulsa, OK

Several papers have shown a link between Morgellons disease and the tick-borne spirochete, Borrelia burgdorferi. North American ticks of several species harbor multiple varieties of bacteria and experiments were conducted to identify any of these putative tick-borne bacterial species that might also be associated with Morgellons disease. Additionally, bacterial species not normally associated with ticks were identified. In samples from Morgellons lesions, DNA was amplified by PCR for the following species: Borrelia burgdorferi, Bartonella henselae, Treponema denticola and Helicobacter pylori. In one subset of samples, areas of skin with no active lesions had no detectable bacterial DNA other than commonly found bacterial populations. Another subset of samples from punch biopsies of skin with no lesions had commonly found skin bacteria and Borrelia burgdorferi, but, not any of the other three bacteria associated with the active lesions. Future research will focus on the hypothesis that localized coinfections are necessary to elicit the formation of active Morgellons lesions.